Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2005 1
2006 2
2007 2
2008 4
2009 6
2010 4
2011 9
2012 4
2013 7
2014 11
2015 12
2016 9
2017 10
2018 17
2019 15
2020 9
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 31416818

113 results
Results by year
Filters applied: . Clear all
Page 1
TRPC6 Binds to and Activates Calpain, Independent of Its Channel Activity, and Regulates Podocyte Cytoskeleton, Cell Adhesion, and Motility.
Farmer LK, Rollason R, Whitcomb DJ, Ni L, Goodliff A, Lay AC, Birnbaumer L, Heesom KJ, Xu SZ, Saleem MA, Welsh GI. Farmer LK, et al. J Am Soc Nephrol. 2019 Oct;30(10):1910-1924. doi: 10.1681/ASN.2018070729. Epub 2019 Aug 15. J Am Soc Nephrol. 2019. PMID: 31416818 Free PMC article.
The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
Verheijden KAT, Sonneveld R, Bakker-van Bebber M, Wetzels JFM, van der Vlag J, Nijenhuis T. Verheijden KAT, et al. J Am Soc Nephrol. 2018 Aug;29(8):2099-2109. doi: 10.1681/ASN.2016111248. Epub 2018 Jun 28. J Am Soc Nephrol. 2018. PMID: 29954830 Free PMC article.
Contribution of Coiled-Coil Assembly to Ca2+/Calmodulin-Dependent Inactivation of TRPC6 Channel and its Impacts on FSGS-Associated Phenotypes.
Polat OK, Uno M, Maruyama T, Tran HN, Imamura K, Wong CF, Sakaguchi R, Ariyoshi M, Itsuki K, Ichikawa J, Morii T, Shirakawa M, Inoue R, Asanuma K, Reiser J, Tochio H, Mori Y, Mori MX. Polat OK, et al. J Am Soc Nephrol. 2019 Sep;30(9):1587-1603. doi: 10.1681/ASN.2018070756. Epub 2019 Jul 2. J Am Soc Nephrol. 2019. PMID: 31266820 Free PMC article.
Synaptopodin Limits TRPC6 Podocyte Surface Expression and Attenuates Proteinuria.
Yu H, Kistler A, Faridi MH, Meyer JO, Tryniszewska B, Mehta D, Yue L, Dryer S, Reiser J. Yu H, et al. J Am Soc Nephrol. 2016 Nov;27(11):3308-3319. doi: 10.1681/ASN.2015080896. Epub 2016 Mar 28. J Am Soc Nephrol. 2016. PMID: 27020855 Free PMC article.
Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
Kistler AD, Singh G, Altintas MM, Yu H, Fernandez IC, Gu C, Wilson C, Srivastava SK, Dietrich A, Walz K, Kerjaschki D, Ruiz P, Dryer S, Sever S, Dinda AK, Faul C, Reiser J. Kistler AD, et al. J Biol Chem. 2013 Dec 20;288(51):36598-609. doi: 10.1074/jbc.M113.488122. Epub 2013 Nov 5. J Biol Chem. 2013. PMID: 24194522 Free PMC article.
Pharmacological inhibition of focal segmental glomerulosclerosis-related, gain of function mutants of TRPC6 channels by semi-synthetic derivatives of larixol.
Urban N, Neuser S, Hentschel A, Köhling S, Rademann J, Schaefer M. Urban N, et al. Br J Pharmacol. 2017 Nov;174(22):4099-4122. doi: 10.1111/bph.13977. Epub 2017 Oct 15. Br J Pharmacol. 2017. PMID: 28800680 Free PMC article.
Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
Sonneveld R, Ferrè S, Hoenderop JG, Dijkman HB, Berden JH, Bindels RJ, Wetzels JF, van der Vlag J, Nijenhuis T. Sonneveld R, et al. Am J Pathol. 2013 Apr;182(4):1196-204. doi: 10.1016/j.ajpath.2012.12.011. Epub 2013 Feb 4. Am J Pathol. 2013. PMID: 23385000
Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
Krall P, Canales CP, Kairath P, Carmona-Mora P, Molina J, Carpio JD, Ruiz P, Mezzano SA, Li J, Wei C, Reiser J, Young JI, Walz K. Krall P, et al. PLoS One. 2010 Sep 20;5(9):e12859. doi: 10.1371/journal.pone.0012859. PLoS One. 2010. PMID: 20877463 Free PMC article.
Angiotensin II Type I Receptor Agonistic Autoantibody Induces Podocyte Injury via Activation of the TRPC6- Calcium/Calcineurin Pathway in Pre-Eclampsia.
Yu Y, Zhang L, Xu G, Wu Z, Li Q, Gu Y, Niu J. Yu Y, et al. Kidney Blood Press Res. 2018;43(5):1666-1676. doi: 10.1159/000494744. Epub 2018 Oct 31. Kidney Blood Press Res. 2018. PMID: 30380548 Free article.
Glycogen synthase kinase 3β dictates podocyte motility and focal adhesion turnover by modulating paxillin activity: implications for the protective effect of low-dose lithium in podocytopathy.
Xu W, Ge Y, Liu Z, Gong R. Xu W, et al. Am J Pathol. 2014 Oct;184(10):2742-56. doi: 10.1016/j.ajpath.2014.06.027. Am J Pathol. 2014. PMID: 25239564 Free PMC article.
113 results
Jump to page
Feedback